Terms: = Lung cancer AND LMO2, RBTN2, 4005, ENSG00000135363, P25791, TTG2, RBTNL1, RHOM2 AND Treatment
4 results:
1. Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy.
Mukhopadhyay S; Huang HY; Lin Z; Ranieri M; Li S; Sahu S; Liu Y; Ban Y; Guidry K; Hu H; Lopez A; Sherman F; Tan YJ; Lee YT; Armstrong AP; Dolgalev I; Sahu P; Zhang T; Lu W; Gray NS; Christensen JG; Tang TT; Velcheti V; Khodadadi-Jamayran A; Wong KK; Neel BG
Cancer Res; 2023 Dec; 83(24):4095-4111. PubMed ID: 37729426
[TBL] [Abstract] [Full Text] [Related]
2. Survival analysis in lung cancer patients with interstitial lung disease.
Alomaish H; Ung Y; Wang S; Tyrrell PN; Zahra SA; Oikonomou A
PLoS One; 2021; 16(9):e0255375. PubMed ID: 34492020
[TBL] [Abstract] [Full Text] [Related]
3. Abemaciclib, a Selective CDK4/6 Inhibitor, Enhances the Radiosensitivity of Non-Small Cell lung cancer
Naz S; Sowers A; Choudhuri R; Wissler M; Gamson J; Mathias A; Cook JA; Mitchell JB
Clin Cancer Res; 2018 Aug; 24(16):3994-4005. PubMed ID: 29716919
[No Abstract] [Full Text] [Related]
4. [Adenocystic bronchial cancer].
Parshin VD; Biriukov IuV; Grigor'eva SP; Vishnevskaia GA
Khirurgiia (Mosk); 2007; (5):26-31. PubMed ID: 17690676
[TBL] [Abstract] [Full Text] [Related]
